Portal de Periódicos da CAPES

The continuing burden of Rh disease 50 years after the introduction of anti-Rh(D) immunoglobin prophylaxis: call to action

2019; Elsevier BV; Volume: 221; Issue: 3 Linguagem: Inglês

10.1016/j.ajog.2019.05.019

1097-6868

Gerard H. A. Visser, Gian Carlo Di Renzo, Steven L. Spitalnik, Gerard H. A. Visser, Gian Carlo Di Renzo, Diogo Ayres‐de‐Campos, María Fernanda Escobar, Eytan R. Barnea, Pooja Shah, Anwar Nasser, Luc de Bernis, Luming Sun, Wanda K. Nicholson, Isabel Lloyd, Salimah R. Walani, Gerhard Theron, William Stones,

Hemoglobinopathies and Related Disorders

Severe morbidity and death because of Rh disease have only been reduced by approximately 50% globally during the last 50 years, despite the advent of anti-Rh(D) immunoglobin prophylaxis, which has resulted in >160,000 perinatal deaths and 100,000 disabilities annually. This apparent failure to take appropriate preventive measures is of great concern. Thus, there is a great need to do much better. We wish to draw attention to the unnecessary continuing burden of Rh disease, to discuss some of the reasons for this failure, and to provide suggestions for a better way forward.